StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Trustworthy Much?

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Oct 28, 2022 6:48pm

110 Views

Post# 35057139

RE:RE:RE:RE:RE:RE:Trustworthy Much?

they've tried projections, they've tried "fluff" news they have tried all other ways, maybe they have com to the conclusion the best option is "show me the money" option. Could be right could be wrong,. My purchase the other day says I'm betting on it.

Liked2Think wrote: The cycle continues with them.

No concrete info of any kind.

As time gets closer to results wishfull thinking will take over until the day comes investors are dissapointed as per usual.

brad129 wrote: Another 2-2.5 weeks we will get some more answers, last quarter they fell just shy of break even, should be hitting that now. No news could be good news, who knows?